{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:31:40Z","timestamp":1793655100528,"version":"4.5.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":1622,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1136\/ijgc-2020-001446","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T01:52:45Z","timestamp":1594345965000},"page":"1169-1176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Role of adjuvant therapy in stage IIIC2 endometrial cancer"],"prefix":"10.1016","volume":"30","author":[{"given":"Giorgio","family":"Bogani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Cappuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jvan","family":"Casarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa Maheswari M","family":"Narasimhulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A","family":"Cliby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen E","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela E","family":"McGree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L","family":"Keeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Weroha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy A","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2020-001446_bb0010","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2020-001446_bb0015","first-page":"125","article-title":"FIGO stages -1988 revisions","volume":"35","author":"Creasman","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2020-001446_bb0025","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/jso.23203","article-title":"New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system","volume":"106","author":"Kato","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0030","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1097\/AOG.0b013e318255060c","article-title":"Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancer","volume":"119","author":"Polterauer","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001446_bb0035","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2011.07.025","article-title":"Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endometrial cancer","volume":"123","author":"Garg","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0040","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ygyno.2005.07.014","article-title":"Resection of lymph node metastases influences survival in stage IIIC endometrial cancer","volume":"99","author":"Havrilesky","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/gyno.1995.1005","article-title":"Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling","volume":"56","author":"Kilgore","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0050","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/gyno.1999.5688","article-title":"Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer","volume":"76","author":"Mariani","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0055","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ygyno.2006.01.032","article-title":"Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients","volume":"101","author":"Mariani","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0060","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ygyno.2006.10.013","article-title":"Endometrial cancer--revisiting the importance of pelvic and para aortic lymph nodes","volume":"104","author":"Aalders","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2008.01.023","article-title":"Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging","volume":"109","author":"Mariani","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/gyno.2001.6157","article-title":"Analysis of FIGO stage IIIC endometrial cancer patients","volume":"81","author":"McMeekin","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0075","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ygyno.2013.06.024","article-title":"Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin\/paclitaxel for stage III (FIGO 2009) endometrial cancer","volume":"130","author":"Milgrom","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0080","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/IGC.0b013e3182978328","article-title":"Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. A single-institution retrospective study","volume":"23","author":"Kuku","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001446_bb0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2007.06.014","article-title":"The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer","volume":"107","author":"Alvarez Secord","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2009.06.035","article-title":"Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation","volume":"115","author":"Klopp","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ygyno.2012.10.010","article-title":"A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer","volume":"128","author":"Secord","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/jog.12344","article-title":"Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence","volume":"40","author":"Bogani","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1136\/ijgc-2020-001446_bb0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ygyno.2013.06.037","article-title":"Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer","volume":"131","author":"AlHilli","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0115","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ygyno.2012.10.009","article-title":"Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer","volume":"128","author":"AlHilli","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0120","first-page":"13","author":"Scully","year":"1994"},{"key":"10.1136\/ijgc-2020-001446_bb0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0360-3016(92)90675-8","article-title":"Endometrial cancer with para-aortic adenopathy: patterns of failure and opportunities for cure","volume":"24","author":"Corn","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2020-001446_bb0130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0360-3016(92)90676-9","article-title":"Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma","volume":"24","author":"Rose","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2020-001446_bb0135","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0360-3016(93)90276-2","article-title":"Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterus","volume":"26","author":"Hicks","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2020-001446_bb0140","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/bjc.1997.313","article-title":"Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy","volume":"75","author":"Onda","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2020-001446_bb0145","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/IGC.0b013e3182915c3e","article-title":"Survival analysis of endometrial cancer patients with positive lymph nodes","volume":"23","author":"Brown","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001446_bb0150","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(09)62002-X","article-title":"Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis","volume":"375","author":"Todo","year":"2010","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2020-001446_bb0155","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","article-title":"Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer","volume":"380","author":"Matei","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2020-001446_bb0160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0165","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial","volume":"20","author":"de Boer","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0170","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e28","article-title":"A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma","volume":"30","author":"Onal","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0175","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ygyno.2017.09.030","article-title":"Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease","volume":"147","author":"Ducie","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0180","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2013.10.002","article-title":"Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer","volume":"132","author":"Kumar","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001446_bb0185","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ygyno.2019.07.006","article-title":"Predictors of extensive lymphatic dissemination and recurrences in node-positive endometrial cancer","volume":"154","author":"Zanfagnin","year":"2019","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25000593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25000593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2020-001446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:25:41Z","timestamp":1753233941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25000593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1048891X25000593"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2020-001446","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of adjuvant therapy in stage IIIC2 endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2020-001446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}